GlaxoSmithKline PLC said it will pay the U.S. government $3 billion to settle several long-running criminal and civil investigations into the company, including allegations that Glaxo marketed some drugs illegally and defrauded the Medicaid program. http://on.wsj.com/sAal3L
Glaxo Settles Off-label Marketing and Medicare Fraud Cases with U.S. for $3 Billion
Posted on November 3rd, 2011 by Sam Kauffman
This entry was posted on Thursday, November 3rd, 2011 at 4:40 pm and is filed under Fraud, Health Care, Uncategorized, Whistle-Blowers. You can follow any responses to this entry through the RSS 2.0 feed. Responses are currently closed, but you can trackback from your own site.